PL2425814T3 - Emulsja typu woda-w-oleju do leczenia choroby oka - Google Patents
Emulsja typu woda-w-oleju do leczenia choroby okaInfo
- Publication number
- PL2425814T3 PL2425814T3 PL10175337T PL10175337T PL2425814T3 PL 2425814 T3 PL2425814 T3 PL 2425814T3 PL 10175337 T PL10175337 T PL 10175337T PL 10175337 T PL10175337 T PL 10175337T PL 2425814 T3 PL2425814 T3 PL 2425814T3
- Authority
- PL
- Poland
- Prior art keywords
- eye
- disease
- treating
- water
- oil type
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10175337.4A EP2425814B1 (en) | 2010-09-03 | 2010-09-03 | A water-in-oil type emulsion for treating a disease of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2425814T3 true PL2425814T3 (pl) | 2013-11-29 |
Family
ID=43662067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10175337T PL2425814T3 (pl) | 2010-09-03 | 2010-09-03 | Emulsja typu woda-w-oleju do leczenia choroby oka |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2425814B1 (pl) |
CY (1) | CY1114688T1 (pl) |
DK (1) | DK2425814T3 (pl) |
ES (1) | ES2426603T3 (pl) |
HR (1) | HRP20130830T1 (pl) |
PL (1) | PL2425814T3 (pl) |
PT (1) | PT2425814E (pl) |
SI (1) | SI2425814T1 (pl) |
SM (1) | SMT201300101B (pl) |
UA (1) | UA111168C2 (pl) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10131910B2 (en) | 2014-07-10 | 2018-11-20 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of Usher syndrome type 2 |
GB201503408D0 (en) | 2015-02-27 | 2015-04-15 | Proqr Therapeutics N V | Oligonucleotides |
US10760076B2 (en) | 2015-10-05 | 2020-09-01 | Proqr Therapeutics Ii B.V. | Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion |
CN109125261B (zh) * | 2016-03-16 | 2021-11-30 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
EP3442503B1 (en) * | 2016-04-12 | 2023-03-15 | Capsular Technologies Pty Ltd. | Injectable composition for delivery of a biologically active agent |
JP7043082B2 (ja) | 2016-04-25 | 2022-03-29 | プロキューアール セラピューティクス ツー ベスローテン フェンノートシャップ | 眼疾患を処置するオリゴヌクレオチド |
GB201616202D0 (en) | 2016-09-23 | 2016-11-09 | Proqr Therapeutics Ii Bv | Antisense oligonucleotides for the treatment of eye deisease |
EP3555291A1 (en) | 2016-12-13 | 2019-10-23 | Stichting Katholieke Universiteit | Antisense oligonucleotides for the treatment of stargardt disease |
EP3824086A1 (en) | 2018-07-19 | 2021-05-26 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4 |
EP3891282A1 (en) | 2018-12-04 | 2021-10-13 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4 |
WO2020157014A1 (en) | 2019-01-28 | 2020-08-06 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of leber's congenital amaurosis |
AU2020259856A1 (en) | 2019-04-18 | 2021-11-18 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of usher syndrome |
CN110090225B (zh) * | 2019-04-19 | 2021-07-16 | 济南康和医药科技有限公司 | 一种依达拉奉氯化钠注射液及其制备方法 |
WO2021023863A1 (en) | 2019-08-08 | 2021-02-11 | Stichting Katholieke Universiteit | Antisense oligonucleotides rescue aberrant splicing of abca4 |
IT201900019190A1 (it) | 2019-10-17 | 2021-04-17 | Univ Politecnica Delle Marche | Derivato dell’epigallocatechina gallato |
WO2021175904A1 (en) | 2020-03-04 | 2021-09-10 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for use in the treatment of usher syndrome |
WO2022090256A1 (en) | 2020-10-26 | 2022-05-05 | Proqr Therapeutics Ii B.V. | Antisense oligonucleotides for the treatment of stargardt disease |
WO2024074670A1 (en) | 2022-10-06 | 2024-04-11 | Stichting Radboud Universitair Medisch Centrum | Antisense oligonucleotides for treatment of usher 2a. exon 68 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
US6417237B1 (en) * | 2000-06-08 | 2002-07-09 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes and compositions containing the same |
JP2005528352A (ja) * | 2002-03-12 | 2005-09-22 | エチファルム | 生体活性物質の持続的放出に用いるためのゲル化特性を有する組成物 |
EP1867323A1 (en) * | 2006-06-13 | 2007-12-19 | Farmatron Ltd. | Pharmaceutical compositions with biological barriers permeation enhancing properties |
US9125807B2 (en) | 2007-07-09 | 2015-09-08 | Incept Llc | Adhesive hydrogels for ophthalmic drug delivery |
CN101854916A (zh) | 2007-10-02 | 2010-10-06 | 博泰迪亚制药公司 | 由凝胶持续递送坎普他汀类似物 |
-
2010
- 2010-09-03 PT PT101753374T patent/PT2425814E/pt unknown
- 2010-09-03 ES ES10175337T patent/ES2426603T3/es active Active
- 2010-09-03 EP EP10175337.4A patent/EP2425814B1/en active Active
- 2010-09-03 SI SI201030338T patent/SI2425814T1/sl unknown
- 2010-09-03 DK DK10175337.4T patent/DK2425814T3/da active
- 2010-09-03 PL PL10175337T patent/PL2425814T3/pl unknown
-
2011
- 2011-02-09 UA UAA201302734A patent/UA111168C2/uk unknown
-
2013
- 2013-09-04 CY CY20131100763T patent/CY1114688T1/el unknown
- 2013-09-05 HR HRP20130830AT patent/HRP20130830T1/hr unknown
- 2013-09-18 SM SM201300101T patent/SMT201300101B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT2425814E (pt) | 2013-09-02 |
ES2426603T3 (es) | 2013-10-24 |
SMT201300101B (it) | 2013-11-08 |
CY1114688T1 (el) | 2016-10-05 |
HRP20130830T1 (en) | 2013-10-11 |
EP2425814B1 (en) | 2013-06-19 |
UA111168C2 (uk) | 2016-04-11 |
EP2425814A1 (en) | 2012-03-07 |
DK2425814T3 (da) | 2013-09-08 |
SI2425814T1 (sl) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130830T1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
HK1258775A1 (zh) | 油包水型乳化防曬化妝品 | |
HK1186660A1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
HK1201438A1 (en) | Treatment of ocular disease | |
HK1196550A1 (en) | Water-in-oil emulsion sunscreen cosmetic | |
HK1169320A1 (zh) | 眼用乳劑 | |
EP2790622A4 (en) | LITHOTRITIC OCULAR TREATMENT | |
EP2760359A4 (en) | METHOD FOR TREATING EYE STATES | |
EP2753275A4 (en) | METHODS OF TREATING OCULAR CONDITIONS | |
EP2559426A4 (en) | WATER IN OIL EMULSION COMPOUND | |
PL2575881T3 (pl) | Przeciwciała swoiste wobec CD160 do leczenia zaburzeń oczu związanych z angiogenezą | |
HK1184066A1 (zh) | 油包水型乳化化妝品 | |
PL2560616T3 (pl) | Emulsja naśladująca łzy | |
EP2680842A4 (en) | METHOD FOR THE TREATMENT OF A DISEASE OR A SENSE OF THE CENTRAL NERVOUS SYSTEM | |
EP2959903A4 (en) | MEDICAMENT FOR THE TREATMENT OF EYE DRESSING | |
HK1207569A1 (en) | Water-in-oil emulsion cosmetic | |
IL230960A0 (en) | A device for the treatment of eye disease | |
EP2692333A4 (en) | COSMETICS WITH WATER IN OIL EMULSION | |
PT2717887T (pt) | Métodos para tratamento ou prevenção da doença do enxerto contra hospedeiro | |
PL2709577T3 (pl) | Urządzenie do badania lub zabiegu na ludzkim oku | |
IL230959A0 (en) | A device for the treatment of eye disease | |
EP2870971A4 (en) | MEDICAMENT FOR THE PREVENTION / TREATMENT OF AN OCULAR DISEASE | |
EP2692329A4 (en) | COSMETIC WATER IN OIL EMULSION COMPOSITION | |
ZA201407215B (en) | Method for emulsion treatment | |
PL2768527T3 (pl) | Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 |